Brown Christopher, Ryan Michael, Kelley Marcella, Thompson Christin, Gunnarsson Candace, Hermiller James
Swedish Heart and Vascular Institute, 550 17th Ave Suite 680, Seattle, WA, 98122, USA.
MPR Consulting, Cincinnati, OH, USA.
Cardiovasc Interv Ther. 2025 Jul 18. doi: 10.1007/s12928-025-01171-0.
While approximately 17% of patients less than 80 years old require coronary access in the 7 years following their TAVR, the need for coronary access among older TAVR patients is unknown.
We examined the percentage of Medicare beneficiaries aged 80-90 years that require coronary access [percutaneous coronary intervention (PCI) or angiogram] in the 8 years following their TAVR using data from the Medicare 5% Standard Analytic File (2011-2021). The need for coronary access in older patients was estimated for all TAVRs, TAVR patients with and without a history of PCI, and TAVR patients with and without coronary artery disease (CAD) using time-to-event models adjusted for age, sex, race, region, ECI score, concomitant CABG, CAD, PCI, and current or recent smoker status. Multivariate log-gamma regressions were used to estimate the total cost of hospitalizations requiring coronary access post-TAVR.
A total of 6845 patients met inclusion criteria. The incidence rates for undergoing PCI or angiogram at 1, 3, 5, and 8 years were 1.9%, 4.0%, 5.5%, and 6.3%, respectively. TAVR patients with PCI demonstrated higher rates of coronary intervention compared to those without PCI (10.2% vs. 6.2% at 8 years, respectively). Similarly, TAVR patients with a prior CAD diagnosis exhibited increased rates of coronary intervention compared to those without a prior CAD diagnosis (7.4% vs. 2.1% at 8 years, respectively). The mean adjusted cost of hospitalizations requiring coronary access was $30,170 [95% Confidence Interval: $27,865-$32,665].
Approximately 6.8% of older TAVR patients require coronary access in the 8 years following their index procedure. The presence of a prior PCI or CAD diagnosis is associated with an increased requirement for subsequent coronary access.
虽然在经导管主动脉瓣置换术(TAVR)后的7年里,约17%的80岁以下患者需要进行冠状动脉介入,但老年TAVR患者对冠状动脉介入的需求尚不清楚。
我们使用医疗保险5%标准分析文件(2011 - 2021年)的数据,研究了80 - 90岁医疗保险受益人群在TAVR术后8年中需要冠状动脉介入[经皮冠状动脉介入治疗(PCI)或血管造影]的百分比。使用针对年龄、性别、种族、地区、ECI评分、同期冠状动脉旁路移植术(CABG)、冠状动脉疾病(CAD)、PCI以及当前或近期吸烟状况进行调整的事件发生时间模型,对所有TAVR患者、有或无PCI病史的TAVR患者以及有或无CAD的TAVR患者中老年患者对冠状动脉介入的需求进行了估计。采用多变量对数伽马回归来估计TAVR术后需要冠状动脉介入的住院总费用。
共有6845名患者符合纳入标准。1年、3年、5年和8年时进行PCI或血管造影的发生率分别为1.9%、4.0%、5.5%和6.3%。与无PCI病史的TAVR患者相比,有PCI病史的TAVR患者冠状动脉介入治疗的发生率更高(8年时分别为10.2%和6.2%)。同样,与无CAD既往诊断的TAVR患者相比,有CAD既往诊断的TAVR患者冠状动脉介入治疗的发生率更高(8年时分别为7.4%和2.1%)。需要冠状动脉介入的住院调整后平均费用为30,170美元[95%置信区间:27,865 - 32,665美元]。
在接受初次TAVR手术的老年患者中,约6.8%在术后8年需要冠状动脉介入。既往有PCI或CAD诊断与后续冠状动脉介入需求增加相关。